Short Description Adenovirus types 4 and 7 Full Vaccine name Adenovirus, type 4 and type 7, live, oral CVX Code 143 Notes This vaccine is administered as 2 tablets. Status Active Last Updated 3/20/2011 Short Description adenovirus, type 4 Full Vaccine name adenovirus vaccine, type 4, live, oral CVX Code 54 Notes Status Inactive Last Updated 5/28/2010 Short Description adenovirus, type 7 Full Vaccine name adenovirus vaccine, type 7, live, oral CVX Code 55 Notes Status Inactive Last Updated 5/28/2010 Short Description adenovirus, unspecified formulation Full Vaccine name adenovirus vaccine, unspecified formulation CVX Code 82 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a adenovirus vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description anthrax immune globulin Full Vaccine name anthrax immune globulin CVX Code 181 Notes Status Active Last Updated 9/4/2020 Short Description Anthrax vaccine, unspecified Full Vaccine name Anthrax vaccine, unspecified CVX Code 319 Notes Unspecified code to record historic administration when specific product is unknown Status Inactive Last Updated 3/15/2024 Short Description Anthrax, post-exposure prophylaxis Full Vaccine name Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis CVX Code 318 Notes National stockpile vaccine (Cyfendus) Status Active Last Updated 1/25/2024 Short Description Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis Full Vaccine name Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis CVX Code 24 Notes Status Active Last Updated 1/25/2024 Short Description AS03 Adjuvant Full Vaccine name AS03 Adjuvant CVX Code 801 Notes This is the adjuvant that is packaged with H5N1 vaccine, adjuvanted Status Active Last Updated 10/27/2020 Short Description BCG Full Vaccine name Bacillus Calmette-Guerin vaccine CVX Code 19 Notes Status Active Last Updated 5/28/2010 Short Description botulinum antitoxin Full Vaccine name botulinum antitoxin CVX Code 27 Notes Status Active Last Updated 9/4/2020 Short Description Chikungunya live attenuated vaccine, 0.5 mL, PF Full Vaccine name Chikungunya, live attenuated vaccine, 0.5 mL, preservative free CVX Code 317 Notes Chikungunya Vaccine Status Active Last Updated 12/20/2023 Short Description Chikungunya, VLP, recombinant, 0.8 mL, PF Full Vaccine name Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free CVX Code 329 Notes Status Active Last Updated 3/18/2025 Short Description cholera, BivWC Full Vaccine name cholera, BivWC CVX Code 173 Notes Status Non-US Last Updated 6/17/2016 Short Description cholera, live attenuated Full Vaccine name cholera, live attenuated CVX Code 174 Notes Status Active Last Updated 6/17/2016 Short Description cholera, unspecified formulation Full Vaccine name cholera vaccine, unspecified formulation CVX Code 26 Notes Status Inactive Last Updated 6/17/2016 Short Description cholera, WC-rBS Full Vaccine name cholera, WC-rBS CVX Code 172 Notes Status Non-US Last Updated 6/17/2016 Short Description CMVIG Full Vaccine name cytomegalovirus immune globulin, intravenous CVX Code 29 Notes Status Active Last Updated 9/4/2020 Short Description COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) Full Vaccine name SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) CVX Code 516 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 4/12/2022 Short Description COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) Full Vaccine name SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) CVX Code 518 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 11/17/2022 Short Description COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) Full Vaccine name SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) CVX Code 510 Notes Pandemic Non-US Vaccine. Authorized by WHO - Counted toward immunity in US Status Non-US Last Updated 11/15/2022 Short Description COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) Full Vaccine name SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) CVX Code 511 Notes Pandemic Non-US Vaccine. Authorized by WHO - Counted toward immunity in US Status Non-US Last Updated 11/15/2022 Short Description COVID-19 IV Non-US Vaccine (COVAXIN) Full Vaccine name SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) CVX Code 502 Notes Pandemic Non-US Vaccine Authorized by WHO 11-3-2021, recognized toward immunity in US, https://extranet.who.int/pqweb/vaccines/who-recommendation-bharat-biotech-international-ltd-covid-19-vaccine-whole-virion Status Non-US Last Updated 11/19/2021 Short Description COVID-19 IV Non-US Vaccine (QAZCOVID-IN) Full Vaccine name SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) CVX Code 501 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 7/15/2021 Short Description COVID-19 LAV Non-US Vaccine (COVIVAC) Full Vaccine name SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) CVX Code 503 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 1/3/2024 Short Description COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna Full Vaccine name SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna CVX Code 519 Notes Pandemic Non-US Vaccine not Authorized by WHO - Is authorized by EU and counted toward immunity in US Status Non-US Last Updated 11/17/2022 Short Description COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech Full Vaccine name SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech CVX Code 520 Notes Pandemic Non-US Vaccine. Authorized by WHO 10/19/2022 - Counted toward immunity in US Status Non-US Last Updated 12/19/2022 Short Description COVID-19 Non-US Vaccine, UNSPECIFIED Full Vaccine name SARS-COV-2 (COVID-19) Non-US Vaccine, UNSPECIFIED CVX Code 500 Notes Unspecified code to be used to record historic Non-US COVID-19 administration. May be used if the specific product or CVX code is not known. Status Non-US Last Updated 9/9/2025 Short Description COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) Full Vaccine name SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) CVX Code 507 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 8/18/2021 Short Description COVID-19 PS Non-US Vaccine (EpiVacCorona) Full Vaccine name SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) CVX Code 509 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 7/15/2021 Short Description COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) Full Vaccine name SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) CVX Code 508 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 1/3/2024 Short Description COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK Full Vaccine name SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK CVX Code 521 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 1/3/2024 Short Description COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL CVX Code 212 Notes Original monovalent Janssen/J&J adult vaccine. All NDCs expired 6/20/2023, not reauthorized by FDA for Fall 2023 US doses. Continue to use to record Jansses/J&J Non-US vaccines administered vaccines administered Status Inactive Last Updated 10/26/2023 Short Description COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL CVX Code 210 Notes WHO authorized pandemic vaccine. Recognized towards immunity in US. AstraZeneca vaccine non-US WHO authorized tradenames/identifiers include VAXZEVRIA, AZD1222, ChAdOx1 nCoV-19, COVISHIELD Status Non-US Last Updated 1/3/2024 Short Description COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology Full Vaccine name SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology CVX Code 506 Notes Pandemic Non-US Vaccine. Authorized by WHO 5/19/2022 - Counted toward immunity in US Status Non-US Last Updated 12/16/2022 Short Description COVID-19 VVnr Non-US Vaccine (Sputnik Light) Full Vaccine name SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) CVX Code 504 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 7/15/2021 Short Description COVID-19 VVnr Non-US Vaccine (Sputnik V) Full Vaccine name SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) CVX Code 505 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 7/15/2021 Short Description COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose CVX Code 226 Notes EUA submission withdrawn by Sanofi Status Never Active Last Updated 3/9/2023 Short Description COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose CVX Code 225 Notes EUA submission withdrawn by Sanofi Status Never Active Last Updated 3/9/2023 Short Description COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose CVX Code 230 Notes Original strain + omicron BA.4/BA.5 bivalent Moderna vaccine (6 mo through 5 yrs), FDA rescinded 9/11/2023 Status Inactive Last Updated 10/26/2023 Short Description COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation CVX Code 301 Notes Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (5 yrs through 11 yrs), FDA rescinded 9/11/2023 Status Inactive Last Updated 10/26/2023 Short Description COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation CVX Code 302 Notes Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (6 mo through 4 yrs), FDA rescinded 09/11/2023 Status Inactive Last Updated 10/26/2023 Short Description COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation CVX Code 300 Notes Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (12 yrs and older). FDA rescinded 09/11/2023. Continue to use to record Non-US vaccines administered (tradename Comirnaty Bivalent) Status Inactive Last Updated 10/26/2023 Short Description COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose CVX Code 229 Notes Original strain + omicron BA.4/BA.5 bivalent Moderna vaccine (6 mo and older), FDA rescinded 9/11/2023. Continue to use to record Non-US vaccines administered (tradename Spikevax Bivalent) Status Inactive Last Updated 10/26/2023 Short Description COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose CVX Code 334 Notes Moderna monovalent new formulation mNEXSPIKE, starting Fall 2025, ages 12 yrs and older, BLA Status Active Last Updated 8/28/2025 Short Description COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation CVX Code 218 Notes Original monovalent Pfizer tris-sucrose formulation (5 yrs through 11 yrs), FDA rescinded 4/18/2023 Status Inactive Last Updated 10/25/2023 Short Description COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose CVX Code 207 Notes Original monovalent Moderna adult vaccine. FDA rescinded all doses for US use 4/18/2023. Continue to used to record historic US Moderna vaccines and those administered in non-US locations (includes tradename Spikevax) Status Inactive Last Updated 10/24/2023 Short Description COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose CVX Code 311 Notes Moderna Fall Seasonal 6 months through 11 years of age Status Active Last Updated 8/30/2024 Short Description COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation CVX Code 219 Notes Original monovalent Pfizer tris-sucrose formulation (6 mo through 4 yrs), FDA rescinded 4/18/2023 Status Inactive Last Updated 10/26/2023 Short Description COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose CVX Code 208 Notes Original monovalent Pfizer adult vaccine (12+ yrs). FDA rescinded all doses for US use 4/18/2023. Continue to use to record historic US Pfizer vaccines and Non-US vaccines administered (includes tradename Comirnaty) Status Inactive Last Updated 11/14/2023 Short Description COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation CVX Code 217 Notes Original monovalent Pfizer tris-sucrose formulation FDA EUA (12+ yrs) and BLA (16+ yrs), FDA rescinded monovalent use 08/31/2022, BLA NDCs not retired until 09/11/2023. Status Inactive Last Updated 11/2/2023 Short Description COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose CVX Code 312 Notes Moderna Fall Seasonal 12 years and older Status Active Last Updated 8/30/2024 Short Description COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose CVX Code 221 Notes Original monovalent Moderna, (Adult) FDA rescinded 4/18/2023, (6 yrs through 11 yrs) FDA rescinded 04/18/2023 Status Inactive Last Updated 10/25/2023 Short Description COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose CVX Code 228 Notes Original monovalent Moderna pediatric vaccine (6 mo through 5 yrs), FDA rescinded 4/18/2023 Status Inactive Last Updated 10/27/2023 Short Description COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose CVX Code 227 Notes Original monovalent Moderna pediatric vaccine (FDA rescinded 4/18/2023). Inactivated 6/14/2022 to use CVX code 221 product instead Status Inactive Last Updated 10/26/2023 Short Description COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose CVX Code 310 Notes Pfizer Fall Seasonal 5 years through 11 years of age Status Active Last Updated 8/30/2024 Short Description COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose CVX Code 308 Notes EUA Revoked 08/27/2024. Pfizer 6 months through 4 years of age. Status Inactive Last Updated 9/9/2025 Short Description COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose CVX Code 309 Notes Pfizer Fall Seasonal 12 years and older Status Active Last Updated 8/30/2024 Short Description COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose CVX Code 211 Notes Original monovalent Novavax vaccine (12+ years), FDA rescinded for US doses 10/03/2023. Continue to use to record Novavax Non-US vaccines administered (includes tradenames NUVAXOVID, COVOVAX) Status Inactive Last Updated 10/24/2023 Short Description COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL Full Vaccine name SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose CVX Code 313 Notes Novavax Fall Seasonal 12 years and older Status Active Last Updated 9/5/2024 Short Description dengue fever tetravalent Full Vaccine name dengue fever vaccine, tetravalent CVX Code 56 Notes Applies to tetravalent product (e.g. DENGVAXIA) Status Active Last Updated 12/11/2024 Short Description Dengue fever, unspecified Full Vaccine name Dengue fever, unspecified formulation CVX Code 330 Notes Use this CVX for historical records where; the formulation of the dengue vaccine administered is not known, or is a non-US product without an associated CVX code. Status Inactive Last Updated 4/30/2025 Short Description diphtheria antitoxin Full Vaccine name diphtheria antitoxin CVX Code 12 Notes Status Active Last Updated 9/4/2020 Short Description DT (pediatric) Full Vaccine name diphtheria and tetanus toxoids, adsorbed for pediatric use CVX Code 28 Notes Retired effective 04/30/2023. All vaccine NDCs retired. No further vaccines expected for this formulation. Status Inactive Last Updated 12/6/2024 Short Description DT, IPV adsorbed Full Vaccine name Diphtheria, Tetanus, Poliomyelitis adsorbed CVX Code 195 Notes This code should be used to document non-US vaccines for DT,IPV such as Revaxis Status Non-US Last Updated 1/17/2023 Short Description DTaP Full Vaccine name diphtheria, tetanus toxoids and acellular pertussis vaccine CVX Code 20 Notes Status Active Last Updated 5/28/2010 Short Description DTaP, 5 pertussis antigens Full Vaccine name diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens CVX Code 106 Notes Status Active Last Updated 5/28/2010 Short Description DTaP, unspecified formulation Full Vaccine name diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation CVX Code 107 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a DTaP vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description DTaP,IPV,Hib,HepB Full Vaccine name Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. CVX Code 146 Notes This vaccine is different from CVX 132. Code may be used to document non-US vaccines (e.g. Hexamin) of the same component formulation Status Active Last Updated 8/10/2022 Short Description DTaP-Hep B-IPV Full Vaccine name DTaP-hepatitis B and poliovirus vaccine CVX Code 110 Notes Status Active Last Updated 5/28/2010 Short Description DTaP-Hib Full Vaccine name DTaP-Haemophilus influenzae type b conjugate vaccine CVX Code 50 Notes Status Inactive Last Updated 3/20/2017 Short Description DTaP-Hib-IPV Full Vaccine name diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) CVX Code 120 Notes Status Active Last Updated 5/28/2010 Short Description DTaP-IPV Full Vaccine name Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated CVX Code 130 Notes Status Active Last Updated 5/28/2010 Short Description DTaP-IPV-HIB-HEP B, historical Full Vaccine name Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. CVX Code 132 Notes This is not the same as CVX 146, Hexavalent vaccine. Status Inactive Last Updated 5/10/2018 Short Description DTAP/IPV/HIB - non-US Full Vaccine name non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) CVX Code 170 Notes This CVX was split off from CVX 102, to correctly identify the contents of the vaccine. Status Non-US Last Updated 5/20/2016 Short Description DTP Full Vaccine name diphtheria, tetanus toxoids and pertussis vaccine CVX Code 01 Notes Status Inactive Last Updated 5/28/2010 Short Description DTP-hepB-Hib Pentavalent Non-US Full Vaccine name Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) CVX Code 198 Notes This represents the non-US pentavalent vaccine. Should be used for historic documentation in US Status Non-US Last Updated 1/17/2023 Short Description DTP-Hib Full Vaccine name DTP-Haemophilus influenzae type b conjugate vaccine CVX Code 22 Notes Status Inactive Last Updated 3/23/2017 Short Description DTP-Hib-Hep B Full Vaccine name DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine CVX Code 102 Notes This CVX has been corrected. This non-US vaccine contained DTP, Hib and Hep B. It was withdrawn in 2007 . Status Non-US Last Updated 5/20/2016 Short Description Ebola Zaire vaccine, live, recombinant, 1mL dose Full Vaccine name Ebola Zaire vaccine, live, recombinant, 1mL dose CVX Code 204 Notes FDA Approved ERVEBO Vaccine. Status Active Last Updated 1/3/2024 Short Description Ebola, unspecified Full Vaccine name Ebola, unspecified CVX Code 214 Notes Status Inactive Last Updated 4/6/2021 Short Description hantavirus Full Vaccine name hantavirus vaccine CVX Code 57 Notes Status Never Active Last Updated 9/9/2020 Short Description HBIG Full Vaccine name hepatitis B immune globulin CVX Code 30 Notes Status Active Last Updated 9/4/2020 Short Description Hep A, adult Full Vaccine name hepatitis A vaccine, adult dosage CVX Code 52 Notes Status Active Last Updated 5/28/2010 Short Description Hep A, IG Full Vaccine name Hepatitis A immune globulin CVX Code 154 Notes Do not use this code. This product may be used for Hep A and other viral infections. The correct vaccine / CVX is 86 (IG). Status Never Active Last Updated 9/9/2020 Short Description Hep A, live attenuated Full Vaccine name Hep A, live attenuated-IM CVX Code 169 Notes This vaccine is not available in the US. Status Non-US Last Updated 5/10/2016 Short Description Hep A, ped/adol, 2 dose Full Vaccine name hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule CVX Code 83 Notes Status Active Last Updated 5/28/2010 Short Description Hep A, ped/adol, 3 dose Full Vaccine name hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule CVX Code 84 Notes This vaccine formulation is inactive and should not be used, except to record historic vaccinations with this formulation. Status Inactive Last Updated 5/28/2010 Short Description Hep A, pediatric, unspecified formulation Full Vaccine name hepatitis A vaccine, pediatric dosage, unspecified formulation CVX Code 31 Notes Do NOT use this code. If formulation is unknown, use CVX 85. There is only one formulation of Hep A, peds. Status Inactive Last Updated 9/30/2010 Short Description Hep A, unspecified formulation Full Vaccine name hepatitis A vaccine, unspecified formulation CVX Code 85 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HepA vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description Hep A-Hep B Full Vaccine name hepatitis A and hepatitis B vaccine CVX Code 104 Notes Status Active Last Updated 5/28/2010 Short Description Hep A-Hep B, pediatric/adolescent Full Vaccine name hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) CVX Code 193 Notes e.g. Twinrix Junior available in Canada Status Non-US Last Updated 8/21/2018 Short Description Hep B, adolescent or pediatric Full Vaccine name hepatitis B vaccine, pediatric or pediatric/adolescent dosage CVX Code 08 Notes This code applies to any standard pediatric formulation of Hepatitis B vaccine. It should not be used for the 2-dose hepatitis B schedule for adolescents (11-15 year olds). Use code 43 for that vaccine. Status Active Last Updated 12/16/2024 Short Description Hep B, adolescent/high risk infant Full Vaccine name hepatitis B vaccine, adolescent/high risk infant dosage CVX Code 42 Notes As of August 27, 1998, Merck ceased distribution of their adolescent/high risk infant hepatitis B vaccine dosage. Code 42 should only be used to record historical records. For current administration of hepatitis B vaccine, pediatric/adolescent dosage, use code 08. Status Inactive Last Updated 5/28/2010 Short Description Hep B, adult Full Vaccine name hepatitis B vaccine, adult dosage CVX Code 43 Notes This code applies to any standard adult dose and schedule. Also use CVX 43 for the FDA approved Recombivax HB 2-dose hepatitis B schedule for adolescents (11-15 year olds) using the adult formulation. Status Active Last Updated 12/12/2024 Short Description Hep B, high-dosage, dialysis or IC Full Vaccine name Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient CVX Code 44 Notes This code is used record patient high dosage vaccine administration for dialysis or immunocompromised patients. For NDCs that are used for both regular vaccine and dialysis/IC high-dosage schedules (e.g. Engerix-B), are mapped to both CVX 43 and CVX 44. CVX code 44 should be utilized to record dialysis/IC dosing. Status Active Last Updated 12/13/2024 Short Description Hep B, unspecified formulation Full Vaccine name hepatitis B vaccine, unspecified formulation CVX Code 45 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HepB vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description Hep C Full Vaccine name hepatitis C vaccine CVX Code 58 Notes Status Never Active Last Updated 9/9/2020 Short Description Hep E Full Vaccine name hepatitis E vaccine CVX Code 59 Notes Status Never Active Last Updated 9/9/2020 Short Description HepB recombinant, 3-antigen, Al(OH)3 Full Vaccine name Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted CVX Code 220 Notes Manufacturer VBI has ceased operations - Prehevbrio Hep B vaccine voluntary recall effective 11/15/2024 Status Inactive Last Updated 12/11/2024 Short Description HepB-CpG Full Vaccine name Hepatitis B vaccine (recombinant), CpG adjuvanted CVX Code 189 Notes Status Active Last Updated 5/10/2018 Short Description herpes simplex 2 Full Vaccine name herpes simplex virus, type 2 vaccine CVX Code 60 Notes Status Never Active Last Updated 9/9/2020 Short Description Hib (HbOC) Full Vaccine name Haemophilus influenzae type b vaccine, HbOC conjugate CVX Code 47 Notes Status Inactive Last Updated 5/28/2010 Short Description Hib (PRP-D) Full Vaccine name Haemophilus influenzae type b vaccine, PRP-D conjugate CVX Code 46 Notes Status Inactive Last Updated 5/28/2010 Short Description Hib (PRP-OMP) Full Vaccine name Haemophilus influenzae type b vaccine, PRP-OMP conjugate CVX Code 49 Notes Status Active Last Updated 5/28/2010 Short Description Hib (PRP-T) Full Vaccine name Haemophilus influenzae type b vaccine, PRP-T conjugate CVX Code 48 Notes Status Active Last Updated 5/28/2010 Short Description Hib, unspecified formulation Full Vaccine name Haemophilus influenzae type b vaccine, conjugate unspecified formulation CVX Code 17 Notes Status Inactive Last Updated 9/30/2010 Short Description Hib-Hep B Full Vaccine name Haemophilus influenzae type b conjugate and Hepatitis B vaccine CVX Code 51 Notes This vaccine may still be in use until the existing lots expire on 8/19/16. Status Inactive Last Updated 3/11/2016 Short Description HIV Full Vaccine name human immunodeficiency virus vaccine CVX Code 61 Notes Status Never Active Last Updated 9/9/2020 Short Description HPV, bivalent Full Vaccine name human papilloma virus vaccine, bivalent CVX Code 118 Notes Status Inactive Last Updated 5/28/2010 Short Description HPV, quadrivalent Full Vaccine name human papilloma virus vaccine, quadrivalent CVX Code 62 Notes Status Active Last Updated 6/2/2020 Short Description HPV, unspecified formulation Full Vaccine name HPV, unspecified formulation CVX Code 137 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HPV vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description HPV9 Full Vaccine name Human Papillomavirus 9-valent vaccine CVX Code 165 Notes Status Active Last Updated 12/11/2014 Short Description IG Full Vaccine name immune globulin, intramuscular CVX Code 86 Notes Status Active Last Updated 9/4/2020 Short Description IG, unspecified formulation Full Vaccine name immune globulin, unspecified formulation CVX Code 14 Notes Status Inactive Last Updated 3/9/2023 Short Description IGIV Full Vaccine name immune globulin, intravenous CVX Code 87 Notes Status Active Last Updated 9/4/2020 Short Description Influenza A monovalent (H5N1), ADJUVANTED-2013 Full Vaccine name Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 CVX Code 160 Notes Approved by FDA 2013, adjuvant is mixed at point of administration. Status Active Last Updated 5/27/2014 Short Description influenza nasal, unspecified formulation Full Vaccine name influenza nasal, unspecified formulation CVX Code 151 Notes This CVX should only be used for historical records where the formulation of nasal flu vaccine is not known. Status Inactive Last Updated 1/28/2013 Short Description Influenza, adjuvanted, quadrivalent, PF Full Vaccine name Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free CVX Code 205 Notes Quadrivalent code starting 2020/2021 season Status Active Last Updated 5/15/2024 Short Description Influenza, adjuvanted, trivalent, PF Full Vaccine name Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free CVX Code 168 Notes Trivalent code reactivated for 2024/2025 season Status Active Last Updated 5/6/2024 Short Description influenza, H5N1-1203 Full Vaccine name influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) CVX Code 123 Notes Status Inactive Last Updated 5/28/2010 Short Description Influenza, high-dose, quadrivalent, PF Full Vaccine name Influenza, high-dose, split virus, quadrivalent, injectable, preservative free CVX Code 197 Notes Quadrivalent code starting season 2020/2021 Status Active Last Updated 5/15/2024 Short Description Influenza, high-dose, trivalent, PF Full Vaccine name Influenza, high-dose, split virus, trivalent, injectable, preservative free CVX Code 135 Notes Trivalent code reactivated for 2024/2025 season Status Active Last Updated 5/2/2024 Short Description Influenza, injectable,quadrivalent, preservative free, pediatric Full Vaccine name Influenza, injectable,quadrivalent, preservative free, pediatric CVX Code 161 Notes Status Active Last Updated 7/29/2024 Short Description influenza, intradermal, quadrivalent, preservative free Full Vaccine name influenza, intradermal, quadrivalent, preservative free, injectable CVX Code 166 Notes No US product available since 2017/2018 flu season Status Inactive Last Updated 12/15/2022 Short Description Influenza, live, quadrivalent, intranasal Full Vaccine name Influenza, live, quadrivalent, intranasal CVX Code 149 Notes Quadrivalent code starting 2013/2014 season Status Active Last Updated 5/15/2024 Short Description Influenza, live, trivalent, intranasal, PF Full Vaccine name Influenza, live, trivalent, intranasal, preservative free CVX Code 111 Notes HCP administered, trivalent code reactivated for 2024/2025 season Status Active Last Updated 7/15/2025 Short Description Influenza, live, trivalent, intranasal, self/caregiver admin, PF Full Vaccine name Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free CVX Code 333 Notes Self or caregiver administered, new starting 2025/2026 season Status Active Last Updated 7/15/2025 Short Description Influenza, MDCK, quadrivalent, PF Full Vaccine name Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free CVX Code 171 Notes Quadrivalent code starting 2016/2017 season Status Active Last Updated 5/15/2024 Short Description Influenza, MDCK, quadrivalent, preservative Full Vaccine name Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative CVX Code 186 Notes Quadrivalent code starting 2017/2018 season Status Active Last Updated 5/15/2024 Short Description Influenza, MDCK, trivalent, PF Full Vaccine name Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free CVX Code 153 Notes Trivalent code reactivated for 2024/2025 season Status Active Last Updated 5/6/2024 Short Description Influenza, MDCK, trivalent, preservative Full Vaccine name Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative CVX Code 320 Notes Trivalent code starting 2024/2025 season Status Active Last Updated 5/15/2024 Short Description Influenza, recombinant, quadrivalent, PF Full Vaccine name Influenza, recombinant, quadrivalent, injectable, preservative free CVX Code 185 Notes Quadrivalent code starting 2017/2018 season Status Active Last Updated 5/15/2024 Short Description Influenza, recombinant, trivalent, PF Full Vaccine name Influenza, recombinant, trivalent, injectable, preservative free CVX Code 155 Notes Trivalent code reactivated for 2024/2025 season Status Active Last Updated 5/6/2024 Short Description influenza, seasonal, intradermal, preservative free Full Vaccine name seasonal influenza, intradermal, preservative free CVX Code 144 Notes IIV3. No US product available since 2014/2015 flu season Status Inactive Last Updated 12/15/2022 Short Description Influenza, Southern Hemisphere Full Vaccine name influenza, Southern Hemisphere, unspecified formulation CVX Code 194 Notes This CVX code should be used to record administration of Southern Hemisphere influenza vaccine where formulation is unknown Status Inactive Last Updated 7/16/2020 Short Description influenza, Southern Hemisphere, high-dose, quadrivalent Full Vaccine name influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free CVX Code 231 Notes Target population 65 and older, starting Southern Hemisphere season 2023 Status Active Last Updated 3/14/2023 Short Description Influenza, Southern Hemisphere, high-dose, trivalent, PF Full Vaccine name Influenza, Southern Hemisphere, high-dose, split virus, trivalent, 0.5 mL, injectable, preservative free CVX Code 337 Notes Code created starting 2026 Southern Hemisphere season Status Active Last Updated 4/9/2026 Short Description influenza, Southern Hemisphere, pediatric, preservative free Full Vaccine name influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free CVX Code 200 Notes Pediatric dose for ages 6-35 months Status Active Last Updated 1/17/2023 Short Description Influenza, Southern Hemisphere, quadrivalent, PF Full Vaccine name Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free CVX Code 201 Notes Represents single dose vial Status Active Last Updated 4/22/2025 Short Description influenza, Southern Hemisphere, quadrivalent, with preservative Full Vaccine name influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative CVX Code 202 Notes Represents multi-dose vial Status Active Last Updated 1/17/2023 Short Description Influenza, Southern Hemisphere, trivalent, PF Full Vaccine name Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free CVX Code 331 Notes Represents single dose vial Status Active Last Updated 4/30/2025 Short Description influenza, split (incl. purified surface antigen) Full Vaccine name influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE CVX Code 15 Notes This code is being retired. It will still be found in older immunization records. It included both preservative free and non-preservative free. Status Inactive Last Updated 9/30/2010 Short Description Influenza, split virus, quadrivalent, PF Full Vaccine name Influenza, split virus, quadrivalent, injectable, preservative free CVX Code 150 Notes Quadrivalent code starting 2013/2014 season Status Active Last Updated 5/15/2024 Short Description Influenza, split virus, quadrivalent, preservative Full Vaccine name Influenza, split virus, quadrivalent, injectable, contains preservative CVX Code 158 Notes Quadrivalent code starting 2013/2014 season Status Active Last Updated 5/15/2024 Short Description Influenza, split virus, trivalent, PF Full Vaccine name Influenza, split virus, trivalent, injectable, preservative free CVX Code 140 Notes Trivalent code reactivated for 2024/2025 season Status Active Last Updated 5/2/2024 Short Description Influenza, split virus, trivalent, preservative Full Vaccine name Influenza, split virus, trivalent, injectable, contains preservative CVX Code 141 Notes Trivalent code reactivated for 2024/2025 season Status Active Last Updated 5/2/2024 Short Description influenza, unspecified formulation Full Vaccine name influenza virus vaccine, unspecified formulation CVX Code 88 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a Influenza vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description influenza, whole Full Vaccine name influenza virus vaccine, whole virus CVX Code 16 Notes Status Inactive Last Updated 5/28/2010 Short Description Influenza-avian, H5, unspecified formulation Full Vaccine name Influenza-avian, H5, unspecified formulation CVX Code 323 Notes Unspecified code H5xx vaccines to be used when specific formulation is unknown - for vaccines administered starting 2024 Status Inactive Last Updated 6/6/2024 Short Description Influenza-avian, H5N8, monovalent, PF Full Vaccine name Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free CVX Code 321 Notes Novel Bird Flu H5N8 Vaccine 2024 Status Active Last Updated 6/12/2024 Short Description Influenza-avian, H5N8, monovalent, preservative Full Vaccine name Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative CVX Code 322 Notes Novel Bird Flu H5N8 Vaccine 2024 Status Active Last Updated 6/12/2024 Short Description IPV Full Vaccine name poliovirus vaccine, inactivated CVX Code 10 Notes Status Active Last Updated 5/28/2010 Short Description Japanese Encephalitis IM Full Vaccine name Japanese Encephalitis vaccine for intramuscular administration CVX Code 134 Notes Status Active Last Updated 5/28/2010 Short Description Japanese encephalitis SC Full Vaccine name Japanese Encephalitis Vaccine SC CVX Code 39 Notes Status Inactive Last Updated 9/24/2015 Short Description Japanese Encephalitis, unspecified formulation Full Vaccine name Japanese Encephalitis vaccine, unspecified formulation CVX Code 129 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a JE vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description Junin virus Full Vaccine name Junin virus vaccine CVX Code 63 Notes Status Never Active Last Updated 9/9/2020 Short Description leishmaniasis Full Vaccine name leishmaniasis vaccine CVX Code 64 Notes Status Never Active Last Updated 9/9/2020 Short Description leprosy Full Vaccine name leprosy vaccine CVX Code 65 Notes Status Never Active Last Updated 9/9/2020 Short Description Lyme disease Full Vaccine name Lyme disease vaccine CVX Code 66 Notes Status Inactive Last Updated 5/28/2010 Short Description M/R Full Vaccine name measles and rubella virus vaccine CVX Code 04 Notes Status Inactive Last Updated 5/28/2010 Short Description malaria Full Vaccine name malaria vaccine CVX Code 67 Notes Status Never Active Last Updated 9/9/2020 Short Description measles Full Vaccine name measles virus vaccine CVX Code 05 Notes Status Inactive Last Updated 8/31/2010 Short Description melanoma Full Vaccine name melanoma vaccine CVX Code 68 Notes Status Never Active Last Updated 9/9/2020 Short Description meningococcal A polysaccharide (non-US) Full Vaccine name meningococcal A polysaccharide vaccine (non-US) CVX Code 191 Notes Status Non-US Last Updated 5/10/2018 Short Description meningococcal AC polysaccharide (non-US) Full Vaccine name meningococcal AC polysaccharide vaccine (non-US) CVX Code 192 Notes Status Non-US Last Updated 5/10/2018 Short Description meningococcal ACWY, unspecified formulation Full Vaccine name meningococcal ACWY vaccine, unspecified formulation CVX Code 108 Notes This CVX is intended for use when one of the meningococcal vaccines containing serogroups A, C, W and Y (conjugate or polysaccaride) was given and the exact formulation was not recorded. It should not be used to record newly administered immunizations. It is not to be used when one of the meningococcal vaccines containing other serogroups was administered. Status Inactive Last Updated 12/1/2015 Short Description meningococcal B, OMV Full Vaccine name meningococcal B vaccine, recombinant, OMV, adjuvanted CVX Code 163 Notes Status Active Last Updated 2/2/2015 Short Description meningococcal B, recombinant Full Vaccine name meningococcal B vaccine, fully recombinant CVX Code 162 Notes Status Active Last Updated 11/3/2014 Short Description meningococcal B, unspecified Full Vaccine name meningococcal B, unspecified formulation CVX Code 164 Notes Status Inactive Last Updated 11/3/2014 Short Description meningococcal C conjugate Full Vaccine name meningococcal C conjugate vaccine CVX Code 103 Notes Status Inactive Last Updated 5/28/2010 Short Description Meningococcal C/Y-HIB PRP Full Vaccine name Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine CVX Code 148 Notes Status Inactive Last Updated 5/11/2018 Short Description meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) Full Vaccine name meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free CVX Code 203 Notes Status Active Last Updated 1/26/2023 Short Description meningococcal MCV4, unspecified formulation Full Vaccine name Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) CVX Code 147 Notes This CVX should only be used for historical doses of meningococcal conjugate vaccine where the formulation is unknown (oligosaccharide vs polysaccharide). It is not the same as CVX 108, Meningococcal, unspecified formulation. This CVX is for unspecified Meningococcal conjugate vaccines. Status Inactive Last Updated 2/8/2012 Short Description Meningococcal MCV4O Full Vaccine name meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) CVX Code 136 Notes Status Active Last Updated 5/28/2010 Short Description meningococcal MCV4P Full Vaccine name meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) CVX Code 114 Notes Status Active Last Updated 5/28/2010 Short Description meningococcal MPSV4 Full Vaccine name meningococcal polysaccharide vaccine (MPSV4) CVX Code 32 Notes Status Inactive Last Updated 10/27/2017 Short Description Meningococcal oligosaccharide (MenACWY), (MenB), PF Full Vaccine name Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free CVX Code 328 Notes Meningococcal pentavalent vaccine strains ABCW and Y Status Active Last Updated 3/18/2025 Short Description Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF Full Vaccine name Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free CVX Code 316 Notes Meningococcal pentavalent vaccine strains ABCW and Y Status Active Last Updated 1/25/2024 Short Description meningococcal, unknown serogroups Full Vaccine name meningococcal vaccine of unknown formulation and unknown serogroups CVX Code 167 Notes This CVX is intended for use when any one of the meningococcal vaccines is recorded and there is no information about which serogroups are protected against. This code should not be used when a newly administered immunization is recorded. Status Inactive Last Updated 12/1/2015 Short Description MMR Full Vaccine name measles, mumps and rubella virus vaccine CVX Code 03 Notes Status Active Last Updated 5/28/2010 Short Description MMRV Full Vaccine name measles, mumps, rubella, and varicella virus vaccine CVX Code 94 Notes Status Active Last Updated 5/28/2010 Short Description mumps Full Vaccine name mumps virus vaccine CVX Code 07 Notes Status Inactive Last Updated 6/18/2015 Short Description no vaccine administered Full Vaccine name no vaccine administered CVX Code 998 Notes Code 998 was added for use in VXU HL7 messages where the OBX segment is nested with the RXA segment, but the message does not contain information about a vaccine administration. An example of this use is to report the vaccines due next for a patient when no vaccine administration is being reported. Status Inactive Last Updated 3/9/2023 Short Description Novel influenza-H1N1-09 Full Vaccine name Novel influenza-H1N1-09, injectable CVX Code 127 Notes Status Inactive Last Updated 8/28/2010 Short Description Novel Influenza-H1N1-09, all formulations Full Vaccine name Novel influenza-H1N1-09, all formulations CVX Code 128 Notes This code is used whenever the actual formulation is not determined or when aggregating all Novel H1N1 Influenza-09 immunizations for reporting to CRA. It should not be used for seasonal influenza vaccine that is not otherwise specified. (NOS) Status Inactive Last Updated 8/28/2010 Short Description Novel Influenza-H1N1-09, nasal Full Vaccine name Novel Influenza-H1N1-09, live virus for nasal administration CVX Code 125 Notes Status Inactive Last Updated 8/28/2010 Short Description Novel influenza-H1N1-09, preservative-free Full Vaccine name Novel influenza-H1N1-09, preservative-free, injectable CVX Code 126 Notes Status Inactive Last Updated 8/28/2010 Short Description OPV ,monovalent, unspecified Full Vaccine name Non-US monovalent oral polio vaccine, unspecified formulation CVX Code 179 Notes This is a non-US vaccine that may be seen in some immunization histories. It is composed of either Type 1, Type 2 or Type 3 oral polio vaccine. Status Non-US Last Updated 1/17/2017 Short Description OPV bivalent Full Vaccine name Non-US bivalent oral polio vaccine (types 1 and 3) CVX Code 178 Notes This is a non-US vaccine that may be seen in some immunization histories. Status Non-US Last Updated 1/17/2017 Short Description OPV, trivalent Full Vaccine name trivalent poliovirus vaccine, live, oral CVX Code 02 Notes This is the OPV used in the US from June 1963 through Dec 1999 and globally through April 2016 Status Inactive Last Updated 6/26/2025 Short Description OPV, Unspecified Full Vaccine name Oral Polio Vaccine, Unspecified formulation CVX Code 182 Notes This code represents an oral polio vaccine where the specific formulation is unknown. Status Inactive Last Updated 1/17/2017 Short Description parainfluenza-3 Full Vaccine name parainfluenza-3 virus vaccine CVX Code 69 Notes Status Inactive Last Updated 1/9/2025 Short Description PCV10 Full Vaccine name pneumococcal conjugate vaccine, 10 valent CVX Code 177 Notes This is a foreign vaccine Status Non-US Last Updated 12/19/2016 Short Description pertussis Full Vaccine name pertussis vaccine CVX Code 11 Notes Status Inactive Last Updated 5/28/2010 Short Description plague Full Vaccine name plague vaccine CVX Code 23 Notes Status Inactive Last Updated 5/17/2018 Short Description Pneumococcal conjugate PCV 13 Full Vaccine name pneumococcal conjugate vaccine, 13 valent CVX Code 133 Notes Status Active Last Updated 5/28/2010 Short Description pneumococcal conjugate PCV 7 Full Vaccine name pneumococcal conjugate vaccine, 7 valent CVX Code 100 Notes Status Inactive Last Updated 6/26/2014 Short Description Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF Full Vaccine name Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free CVX Code 215 Notes Status Active Last Updated 8/18/2021 Short Description Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF Full Vaccine name Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free CVX Code 216 Notes Status Active Last Updated 3/9/2023 Short Description Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF Full Vaccine name Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free CVX Code 327 Notes Status Active Last Updated 7/11/2024 Short Description Pneumococcal Conjugate, unspecified formulation Full Vaccine name Pneumococcal Conjugate, unspecified formulation CVX Code 152 Notes This CVX should only be used for historical records where the formulation of pneumococcal conjugate vaccine is not known. Status Inactive Last Updated 1/28/2013 Short Description pneumococcal polysaccharide PPV23 Full Vaccine name pneumococcal polysaccharide vaccine, 23 valent CVX Code 33 Notes Status Active Last Updated 5/28/2010 Short Description pneumococcal, unspecified formulation Full Vaccine name pneumococcal vaccine, unspecified formulation CVX Code 109 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a pneumococcal vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description polio, unspecified formulation Full Vaccine name poliovirus vaccine, unspecified formulation CVX Code 89 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a polio vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description Poliovirus, inactivated, fractional-dose (fIPV) Full Vaccine name Poliovirus, inactivated, fractional-dose (fIPV) CVX Code 324 Notes Non-US polio vaccine administered since 2016 Status Non-US Last Updated 6/5/2024 Short Description Q fever Full Vaccine name Q fever vaccine CVX Code 70 Notes Status Never Active Last Updated 9/9/2020 Short Description Rabies - IM Diploid cell culture Full Vaccine name Human Rabies vaccine from human diploid cell culture CVX Code 175 Notes Status Active Last Updated 10/18/2016 Short Description Rabies - IM fibroblast culture Full Vaccine name Human rabies vaccine from Chicken fibroblast culture CVX Code 176 Notes Status Active Last Updated 10/18/2016 Short Description rabies, intradermal injection Full Vaccine name rabies vaccine, for intradermal injection CVX Code 40 Notes Status Inactive Last Updated 6/18/2015 Short Description rabies, intramuscular injection Full Vaccine name rabies vaccine, for intramuscular injection RETIRED CODE CVX Code 18 Notes This CVX code has been retired. It is replace by CVX 175, or CVX 176. It will continue to be found in historic records. Status Inactive Last Updated 10/18/2016 Short Description rabies, unspecified formulation Full Vaccine name rabies vaccine, unspecified formulation CVX Code 90 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a rabies vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description RESERVED - do not use Full Vaccine name RESERVED - do not use CVX Code 99 Notes Code 99 will not be used in this table to avoid confusion with code 999. Status Inactive Last Updated 9/9/2020 Short Description Respiratory syncytial virus (RSV) MAB, unspecified Full Vaccine name Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified CVX Code 315 Notes Unspecified, for historic records where the specific RSV MAB administered is not known Status Inactive Last Updated 9/19/2023 Short Description Respiratory syncytial virus (RSV) vaccine, unspecified Full Vaccine name Respiratory syncytial virus (RSV) vaccine, unspecified CVX Code 314 Notes Unspecified, for historic records where the specific vaccine administered is not known Status Inactive Last Updated 9/19/2023 Short Description Respiratory syncytial virus (RSV), unspecified Full Vaccine name Respiratory syncytial virus (RSV), unspecified CVX Code 304 Notes Unspecified, for historic records where it is not known if RSV vaccine or RSV MAB was administered Status Inactive Last Updated 1/3/2024 Short Description rheumatic fever Full Vaccine name rheumatic fever vaccine CVX Code 72 Notes Status Never Active Last Updated 9/9/2020 Short Description Rho(D) - Unspecified formulation Full Vaccine name Rho(D) Unspecified formulation CVX Code 159 Notes Status Inactive Last Updated 3/9/2023 Short Description Rho(D) -IG IM Full Vaccine name Rho(D) Immune globulin - IM CVX Code 157 Notes This immune globulin may be administered IM only. Status Active Last Updated 9/4/2020 Short Description Rho(D)-IG Full Vaccine name Rho(D) Immune globulin- IV or IM CVX Code 156 Notes This immune globulin may be administered either IM or IV. Status Active Last Updated 9/4/2020 Short Description Rift Valley fever Full Vaccine name Rift Valley fever vaccine CVX Code 73 Notes Status Never Active Last Updated 9/9/2020 Short Description RIG Full Vaccine name rabies immune globulin CVX Code 34 Notes Status Active Last Updated 9/4/2020 Short Description rotavirus, monovalent Full Vaccine name rotavirus, live, monovalent vaccine CVX Code 119 Notes Status Active Last Updated 5/28/2010 Short Description rotavirus, pentavalent Full Vaccine name rotavirus, live, pentavalent vaccine CVX Code 116 Notes Status Active Last Updated 5/28/2010 Short Description rotavirus, tetravalent Full Vaccine name rotavirus, live, tetravalent vaccine CVX Code 74 Notes Status Inactive Last Updated 5/28/2010 Short Description rotavirus, unspecified formulation Full Vaccine name rotavirus vaccine, unspecified formulation CVX Code 122 Notes Status Inactive Last Updated 9/30/2010 Short Description RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF Full Vaccine name Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free CVX Code 305 Notes Adults 60 years and older, pregnant individuals Status Active Last Updated 8/7/2024 Short Description RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF Full Vaccine name Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ , (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free CVX Code 332 Notes RSV mAb for neonates and infants born during or entering first RSV season (Enflonsia) Status Active Last Updated 7/3/2025 Short Description RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months Full Vaccine name Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 0.5 mL, neonates and children to 24 months CVX Code 306 Notes RSV monoclonal antibody (Beyfortus) Status Active Last Updated 7/25/2023 Short Description RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months Full Vaccine name Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 1 mL, neonates and children to 24 months CVX Code 307 Notes RSV monoclonal antibody (Beyfortus) Status Active Last Updated 8/9/2023 Short Description RSV, mRNA, injectable, PF Full Vaccine name Respiratory syncytial virus (RSV), mRNA, injectable, preservative free CVX Code 326 Notes mRNA RSV vaccine added 2024 Status Active Last Updated 8/30/2024 Short Description RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF Full Vaccine name Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free CVX Code 303 Notes Adults 60 years and older Status Active Last Updated 6/6/2023 Short Description RSV-IGIV Full Vaccine name respiratory syncytial virus immune globulin, intravenous CVX Code 71 Notes No active NDCs or CPT codes associated to this CVX Status Inactive Last Updated 7/19/2023 Short Description RSV-MAb Full Vaccine name respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular CVX Code 93 Notes Status Active Last Updated 9/4/2020 Short Description RSV-MAb (new) Full Vaccine name respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular CVX Code 145 Notes Status Never Active Last Updated 9/9/2020 Short Description rubella Full Vaccine name rubella virus vaccine CVX Code 06 Notes Status Inactive Last Updated 6/18/2015 Short Description rubella/mumps Full Vaccine name rubella and mumps virus vaccine CVX Code 38 Notes Status Inactive Last Updated 5/28/2010 Short Description SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED Full Vaccine name SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED CVX Code 213 Notes Unspecified code for COVID-19 not to be used to record patient US administration. May be used to record historic US administration if product not known. CVX code 500 should be used to record Non-US vaccine where product is not known. Status Inactive Last Updated 9/9/2025 Short Description SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) Full Vaccine name SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) CVX Code 514 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 4/12/2022 Short Description SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) Full Vaccine name SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) CVX Code 513 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 4/12/2022 Short Description SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) Full Vaccine name SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) CVX Code 517 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 4/12/2022 Short Description SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) Full Vaccine name SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) CVX Code 515 Notes Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Status Non-US Last Updated 4/12/2022 Short Description SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) Full Vaccine name SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) CVX Code 512 Notes Pandemic Non-US Vaccine not Authorized by WHO - ACIP does recognize towards immunity in US Status Non-US Last Updated 4/12/2022 Short Description Staphylococcus bacterio lysate Full Vaccine name Staphylococcus bacteriophage lysate CVX Code 76 Notes Status Inactive Last Updated 3/9/2023 Short Description Td (adult) Full Vaccine name tetanus and diphtheria toxoids, not adsorbed, for adult use CVX Code 138 Notes Note that this Td is not adsorbed. Status Inactive Last Updated 9/30/2010 Short Description Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed Full Vaccine name tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) CVX Code 09 Notes Status Active Last Updated 10/27/2017 Short Description Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed Full Vaccine name tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) CVX Code 113 Notes Status Active Last Updated 1/25/2024 Short Description Td(adult) unspecified formulation Full Vaccine name Td(adult) unspecified formulation CVX Code 139 Notes This CVX code allows reporting of a historic vaccination when the formulation is unknown (for example, when recording a Td vaccination when noted on a vaccination card) Status Inactive Last Updated 8/27/2019 Short Description Td, adsorbed, preservative free, adult use, Lf unspecified Full Vaccine name tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified CVX Code 196 Notes Used when Td Lf specification is unknown Status Active Last Updated 8/15/2019 Short Description Tdap Full Vaccine name tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed CVX Code 115 Notes Status Active Last Updated 5/28/2010 Short Description tetanus immune globulin Full Vaccine name tetanus immune globulin CVX Code 180 Notes This record duplicates CVX 13 (TIG). Do not use CVX 180. Status Inactive Last Updated 9/9/2020 Short Description tetanus toxoid, adsorbed Full Vaccine name tetanus toxoid, adsorbed CVX Code 35 Notes Status Inactive Last Updated 8/14/2015 Short Description tetanus toxoid, not adsorbed Full Vaccine name tetanus toxoid, not adsorbed CVX Code 142 Notes Status Inactive Last Updated 8/14/2015 Short Description tetanus toxoid, unspecified formulation Full Vaccine name tetanus toxoid, unspecified formulation CVX Code 112 Notes Status Inactive Last Updated 9/30/2010 Short Description Tick-borne encephalitis vaccine (non-US) Full Vaccine name Tick-borne encephalitis vaccine (non-US) CVX Code 77 Notes Non-US vaccine Status Non-US Last Updated 3/4/2022 Short Description Tick-borne encephalitis, inactivated, PF, 0.25mL Full Vaccine name Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose CVX Code 223 Notes Pediatric dose vaccine Status Active Last Updated 3/3/2022 Short Description Tick-borne encephalitis, inactivated, PF, 0.5mL Full Vaccine name Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose CVX Code 224 Notes Adult dose vaccine Status Active Last Updated 3/4/2022 Short Description Tick-borne encephalitis, unspecified Full Vaccine name Tick-borne encephalitis vaccine, unspecified CVX Code 222 Notes Unspecified Code - should only be used when specific vaccine administered is unknown Status Inactive Last Updated 3/16/2022 Short Description TIG Full Vaccine name tetanus immune globulin CVX Code 13 Notes Status Active Last Updated 9/4/2020 Short Description TST, unspecified formulation Full Vaccine name tuberculin skin test; unspecified formulation CVX Code 98 Notes TB Skin test is not vaccine. Status Inactive Last Updated 3/9/2023 Short Description TST-OT tine test Full Vaccine name tuberculin skin test; old tuberculin, multipuncture device CVX Code 95 Notes TB Skin test is not vaccine. Status Inactive Last Updated 3/9/2023 Short Description TST-PPD intradermal Full Vaccine name tuberculin skin test; purified protein derivative solution, intradermal CVX Code 96 Notes TB Skin test is not vaccine. Status Inactive Last Updated 3/9/2023 Short Description TST-PPD tine test Full Vaccine name tuberculin skin test; purified protein derivative, multipuncture device CVX Code 97 Notes TB Skin test is not vaccine. Status Inactive Last Updated 3/9/2023 Short Description tularemia vaccine Full Vaccine name tularemia vaccine CVX Code 78 Notes Status Inactive Last Updated 5/28/2010 Short Description Typhoid conjugate vaccine (TCV) Full Vaccine name Typhoid conjugate vaccine (non-US) CVX Code 190 Notes Status Non-US Last Updated 1/17/2023 Short Description typhoid, oral Full Vaccine name typhoid vaccine, live, oral CVX Code 25 Notes Status Active Last Updated 5/28/2010 Short Description typhoid, parenteral Full Vaccine name typhoid vaccine, parenteral, other than acetone-killed, dried CVX Code 41 Notes Status Inactive Last Updated 8/13/2015 Short Description typhoid, parenteral, AKD (U.S. military) Full Vaccine name typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) CVX Code 53 Notes Status Inactive Last Updated 6/18/2015 Short Description typhoid, unspecified formulation Full Vaccine name typhoid vaccine, unspecified formulation CVX Code 91 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a typhoid vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description typhoid, ViCPs Full Vaccine name typhoid Vi capsular polysaccharide vaccine CVX Code 101 Notes Status Active Last Updated 5/28/2010 Short Description typhus, historical Full Vaccine name Historical record of a typhus vaccination CVX Code 131 Notes Status Inactive Last Updated 5/28/2010 Short Description unknown Full Vaccine name unknown vaccine or immune globulin CVX Code 999 Notes This CVX code has little utility and should rarely be used. Status Inactive Last Updated 10/27/2020 Short Description vaccinia (smallpox) diluted Full Vaccine name vaccinia (smallpox) vaccine, diluted CVX Code 105 Notes Status Inactive Last Updated 5/28/2010 Short Description Vaccinia (smallpox, monkeypox), live Full Vaccine name Vaccinia (smallpox, monkeypox) vaccine, live CVX Code 75 Notes Status Active Last Updated 11/19/2025 Short Description Vaccinia (smallpox, monkeypox), unspecified Full Vaccine name Vaccinia (smallpox, monkeypox), unspecified CVX Code 325 Notes Use this CVX for historical records where; the formulation administered is not known, or is a non-US product without an associated CVX code. Status Inactive Last Updated 11/19/2025 Short Description vaccinia immune globulin Full Vaccine name vaccinia immune globulin CVX Code 79 Notes Status Active Last Updated 9/4/2020 Short Description Vaccinia, smallpox monkeypox vaccine live, PF, SQ or ID injection Full Vaccine name Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection CVX Code 206 Notes Associated to FDA US Licensed product JYNNEOS, non-US tradenames IMVANEX, IMVAMUNE. Review CDC & FDA guidance for updates regarding administration Status Active Last Updated 11/19/2025 Short Description varicella Full Vaccine name varicella virus vaccine CVX Code 21 Notes Status Active Last Updated 5/28/2010 Short Description VEE, inactivated Full Vaccine name Venezuelan equine encephalitis, inactivated CVX Code 81 Notes Status Inactive Last Updated 5/28/2010 Short Description VEE, live Full Vaccine name Venezuelan equine encephalitis, live, attenuated CVX Code 80 Notes Status Inactive Last Updated 5/28/2010 Short Description VEE, unspecified formulation Full Vaccine name Venezuelan equine encephalitis vaccine, unspecified formulation CVX Code 92 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a VEE vaccination when noted on a vaccination card) Status Inactive Last Updated 9/30/2010 Short Description VZIG Full Vaccine name varicella zoster immune globulin CVX Code 36 Notes Status Active Last Updated 9/4/2020 Short Description VZIG (IND) Full Vaccine name varicella zoster immune globulin (Investigational New Drug) CVX Code 117 Notes Status Never Active Last Updated 9/9/2020 Short Description yellow fever live Full Vaccine name yellow fever vaccine live CVX Code 37 Notes This is the YF vaccine that has been available in the US for years. It is stabilized with sorbitol and gelatin. Status Active Last Updated 3/7/2024 Short Description Yellow fever vaccine live - alt Full Vaccine name Yellow fever vaccine live - alternative formulation for vaccine shortage CVX Code 183 Notes This CVX is associated to an FDA unapproved drug to be used when there is a drug shortage. Stabilized with sorbitol and lactose and has been used outside the US for some time. Status Active Last Updated 3/7/2024 Short Description Yellow fever, unspecified Full Vaccine name Yellow fever vaccine, unspecified formulation CVX Code 184 Notes Status Inactive Last Updated 3/7/2024 Short Description zoster live Full Vaccine name zoster vaccine, live CVX Code 121 Notes Zostavax vaccine associated to this CVX Code retired 10/2022 Status Inactive Last Updated 12/17/2024 Short Description zoster recombinant Full Vaccine name zoster vaccine recombinant CVX Code 187 Notes Status Active Last Updated 10/27/2017 Short Description zoster, unspecified formulation Full Vaccine name zoster vaccine, unspecified formulation CVX Code 188 Notes This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a zoster vaccination when noted on a vaccination card) Status Inactive Last Updated 10/27/2017